Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

  • Etienne Dardenne
  • , Sandra Pierredon
  • , Keltouma Driouch
  • , Lise Gratadou
  • , Magali Lacroix-Triki
  • , Micaela Polay Espinoza
  • , Eleonora Zonta
  • , Sophie Germann
  • , Hussein Mortada
  • , Jean Philippe Villemin
  • , Martin Dutertre
  • , Rosette Lidereau
  • , Stéphan Vagner
  • , Didier Auboeuf

Research output: Contribution to journalArticlepeer-review

Abstract

Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA-and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.

Original languageEnglish
Pages (from-to)1139-1146
Number of pages8
JournalNature Structural and Molecular Biology
Volume19
Issue number11
DOIs
Publication statusPublished - 1 Jan 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness'. Together they form a unique fingerprint.

Cite this